Skip to main content
logo
Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
2.130
-0.060 (-2.74%)
At close: Aug 28, 2026, 4:00 PM EDT
2.148
+0.018 (0.85%)
After-hours: Aug 28, 2026, 7:59 PM EDT

Tenax Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1224952187526
Market Cap Growth
-48.46%126.39%3233.86%31.60%-81.01%11.69%
Enterprise Value
4395120-4118
Last Close Price
2.1312.196.1921.97178.241664.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.975.102.380.813.346.18
P/TBV Ratio
1.075.102.380.813.346.18

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---0.060.540.07
Net Debt / Equity Ratio
-1.04-1.00-1.03-1.15-0.88-1.25
Net Debt / EBITDA Ratio
--4.871.130.120.17
Net Debt / FCF Ratio
2.562.736.401.570.120.49
Quick Ratio
14.6113.6320.212.731.153.57
Current Ratio
15.0714.5720.603.261.743.64
Return on Equity (ROE)
-59.80%-55.64%-35.17%-160.80%-385.12%-732.21%
Return on Assets (ROA)
-37.70%-35.08%-22.48%-68.21%-147.02%-306.43%
Return on Capital Employed (ROCE)
-60.40%-58.10%-21.20%-101.70%-709.90%-712.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-53.16%-10.64%-8.06%-117.68%-221.89%-123.88%
FCF Yield
-37.73%-7.24%-6.78%-90.10%-228.78%-41.43%
Buyback Yield / Dilution
-31.87%-156.80%-6046.87%-1250.92%-43.00%-
SEC Filings: 10-K · 10-Q